MARKET

MBX

MBX

MBX Biosciences Inc
NASDAQ
55.94
+1.43
+2.62%
After Hours: 55.94 0 0.00% 19:30 11/13 EST
OPEN
54.49
PREV CLOSE
54.51
HIGH
57.11
LOW
52.94
VOLUME
855.45K
TURNOVER
--
52 WEEK HIGH
72.64
52 WEEK LOW
23.07
MARKET CAP
2.78B
P/E (TTM)
-18.2882
1D
5D
1M
3M
1Y
5Y
1D
Nvidia downgraded, AMD upgraded: Wall Street’s top analyst calls
TipRanks · 2d ago
This Kimball Electronics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Benzinga · 2d ago
MBX Biosciences Price Target Announced at $90.00/Share by HC Wainwright & Co.
Dow Jones · 2d ago
MBX Biosciences Initiated at Buy by HC Wainwright & Co.
Dow Jones · 2d ago
MBX Biosciences initiated with a Buy at H.C. Wainwright
TipRanks · 2d ago
HC Wainwright & Co. Initiates Coverage On MBX Biosciences with Buy Rating, Announces Price Target of $90
Benzinga · 2d ago
MBX Biosciences, Inc. (MBX) Receives a Buy from Stifel Nicolaus
TipRanks · 3d ago
MBX Biosciences, Inc. (MBX) Receives a Buy from Oppenheimer
TipRanks · 3d ago
More
About MBX
MBX Biosciences, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of novel precision peptide therapies based on its proprietary PEP platform, for the treatment of endocrine and metabolic disorders. It is advancing a pipeline of novel candidates for endocrine and metabolic disorders with clinically validated targets and proven endpoints for regulatory approval. Its pipeline includes canvuparatide (MBX 2109) for the treatment of chronic hypoparathyroidism in Phase III development and an obesity portfolio that includes MBX 4291 in Phase I development and MBX 5765 and MBX 6180 in preclinical development, as well as additional discovery candidates. Its lead obesity product candidate, MBX 4291, is designed to be a long-acting and highly potent glucagon-like peptide 1 (GLP-1) / glucose-dependent insulinotropic polypeptide (GIP) co-agonist prodrug with the goal of potential once-monthly dosing frequency.

Webull offers MBX Biosciences, Inc. stock information, including NASDAQ: MBX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MBX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MBX stock methods without spending real money on the virtual paper trading platform.